Abstract:Background: Despite the high prevalence of HIV in men who have sex with men (MSM) in Bangkok, little investment in HIV prevention for MSM has been made. HIV testing and treatment coverage remains low. Through a pragmatic programme-planning approach, we assess possible service linkage and provision of HIV testing and antiretroviral treatment (ART) to MSM in Bangkok, and the most cost-effective scale-up strategy. Methods: We obtained epidemiological and service capacity data from the Thai National Health Security Office database for 2011. We surveyed 13 representative medical facilities for detailed operational costs of HIV-related services for sexually active MSM (defined as having sex with men in the past 12 months) in metropolitan Bangkok. We estimated the costs of various ART scale-up scenarios, accounting for geographical accessibility across Bangkok. We used an HIV transmission population-based model to assess the cost-effectiveness of the scenarios. Findings: For present HIV testing (23% [95% CI 17-36] of MSM at high risk in 2011) and ART provision (20% of treatment-eligible MSM at high risk on ART in 2011) to be sustained, a US$73·8 million ($51·0 million to $97·0 million) investment during the next decade would be needed, which would link an extra 43,000 (27,900-58,000) MSM at high risk to HIV testing and 5100 (3500-6700) to ART, achieving an ART coverage of 44% for MSM at high risk in 2022. An additional $55·3 million investment would link an extra 46,700 (30,300-63,200) MSM to HIV testing and 12,600 (8800-16,600) to ART, achieving universal ART coverage of this population by 2022. This increased investment is achievable within present infrastructure capacity. Consequently, an estimated 5100 (3600-6700) HIV-related deaths and 3700 (2600-4900) new infections could be averted in MSM by 2022, corresponding to a 53% reduction in deaths and a 35% reduction in infections from 2012 levels. The expansion would cost an estimated $10,809 (9071-13,274) for each HIV-related death, $14,783 (12,389-17,960) per new infection averted, and $351 (290-424) per disability-adjusted life-year averted. Interpretation: Spare capacity in Bangkok's medical facilities can be used to expand ART access for MSM with large epidemiological benefits. The expansion needs increased funding directed to MSM services, but given the epidemiological trends, is probably cost effective. Our modelling approach and outcomes are likely to be applicable to other settings. Funding: World Bank Group and Australian National Health and Medical Research Council.

Projecting the Epidemiological Effect, Cost-Effectiveness and Transmission of Hiv Drug Resistance in Vietnam Associated with Viral Load Monitoring Strategies

Estimating the Cost-Effectiveness of Hiv Prevention Programmes in Vietnam, 2006-2010: A Modelling Study

Cost-Effectiveness of Antiretroviral Therapy Expansion Strategies in Vietnam

A Review of the Extent of HIV Drug Resistance in Vietnam

Pretreatment HIV-1 Drug Resistance to First-Line Drugs: Results from a Baseline Assessment of a Large Cohort Initiating ART in Vietnam, 2009-10

Returns on Investments of HIV Prevention in Vietnam

Hiv Drug Resistance And Its Impact On Antiretroviral Therapy In Chinese Hiv-Infected Patients

Determinants of Virological Failure after 1 Year's Antiretroviral Therapy in Vietnamese People with HIV: Findings from a Retrospective Cohort of 13 Outpatient Clinics in Six Provinces.

Incidence And Associated Factors Of Hiv Drug Resistance In Chinese Hiv-Infected Patients Receiving Antiretroviral Treatment

Viral load suppression and HIV-1 drug resistance mutations in persons with HIV on TLD/TAFED in Zambia

On call. I am 46 years old and have arthritis of my knees. Ibuprofen helps, but I still have pain. Should I consider the new joint injections?

Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study

Trends in and Determinants of Loss to Follow Up and Early Mortality in a Rapid Expansion of the Antiretroviral Treatment Program in Vietnam: Findings from 13 Outpatient Clinics.

Myasthenia gravis: disease severity and prognosis

Determinants of Antiretroviral Therapy Initiation and Treatment Outcomes for People Living with HIV in Vietnam.

Detection of antiretroviral drug-resistant mutations and HIV-1 subtypes in circulation among men who have sex with men, SEM females and female sex workers: results of Vietnam’s HIV Sentinel Surveillance Plus (HSS+) system, 2018 – 2020

Structural Barriers to Timely Initiation of Antiretroviral Treatment in Vietnam: Findings from Six Outpatient Clinics

Utilization of a basic care and prevention package by HIV-infected persons in Uganda

Health and Economic Impacts of Introducing Vaccae and Enhanced Drug-Resistant Tuberculosis Management Strategies in China.

Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China

The viral load monitoring cascade in HIV treatment programmes in sub-Saharan Africa: a systematic review